Neuroscience
For when you've had enough of reading journal articles:
The sleeping pill that is awakening coma patients.
The lady who changed her husband's behaviour using animal training techniques (free registration required).
Does neuroscience hold the key to the placebo effect?
What happened when the psychiatrist went for psychoanalysis?
- Business World: Takeda's Ramelteon (tak-375)
A Reuters report:Takeda may extend sleeping pill's use for Alzheimer's Mon Jul 11, 2005 05:41 AM ET TOKYO, July 11 (Reuters) - Japan's biggest drug maker, Takeda Pharmaceutical Co. Ltd ... said on Monday it is on track to release a sleeping...
- Reminyl (galantamine Hydrobromide) (continued)
Safety Concerns Reported on J.& J. Alzheimer's Drug By ANDREW POLLACK New York Times Published: January 22, 2005 Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated...
- Watch Out: Under-recognized, Under-treated Means Ad Blitz
An interesting piece on what's about to hit consumers: the marketing of Lunesta (eszopiclone): You May Want to Sleep on It Enter the Next 'Miracle' Drug: A Sleeping Pill You Can Take Long-Term. Ads for Lunesta Won't Likely Give That...
- Issues In Clinical Trials: Gdnf And Parkinson Disease
Today's New York Times includes a front-page article about the culture of clinical-trials research: what happens to participant subjects when an experimental drug is pulled from testing and, among other issues, how teasing apart placebo-based from...
- The Placebo Effect Is Stronger Than Ever
The September 2009 issue of Wired has a terrific article about the placebo effect / response. Steve Silberman writes in "Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why" that the placebo effect in drug clinical trials has been...
Neuroscience
Elsewhere
For when you've had enough of reading journal articles:The sleeping pill that is awakening coma patients.
The lady who changed her husband's behaviour using animal training techniques (free registration required).
Does neuroscience hold the key to the placebo effect?
What happened when the psychiatrist went for psychoanalysis?
- Business World: Takeda's Ramelteon (tak-375)
A Reuters report:Takeda may extend sleeping pill's use for Alzheimer's Mon Jul 11, 2005 05:41 AM ET TOKYO, July 11 (Reuters) - Japan's biggest drug maker, Takeda Pharmaceutical Co. Ltd ... said on Monday it is on track to release a sleeping...
- Reminyl (galantamine Hydrobromide) (continued)
Safety Concerns Reported on J.& J. Alzheimer's Drug By ANDREW POLLACK New York Times Published: January 22, 2005 Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated...
- Watch Out: Under-recognized, Under-treated Means Ad Blitz
An interesting piece on what's about to hit consumers: the marketing of Lunesta (eszopiclone): You May Want to Sleep on It Enter the Next 'Miracle' Drug: A Sleeping Pill You Can Take Long-Term. Ads for Lunesta Won't Likely Give That...
- Issues In Clinical Trials: Gdnf And Parkinson Disease
Today's New York Times includes a front-page article about the culture of clinical-trials research: what happens to participant subjects when an experimental drug is pulled from testing and, among other issues, how teasing apart placebo-based from...
- The Placebo Effect Is Stronger Than Ever
The September 2009 issue of Wired has a terrific article about the placebo effect / response. Steve Silberman writes in "Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why" that the placebo effect in drug clinical trials has been...